Skip to main content
Log in

Detection of the pharmaceutical agent glaucine as a recreational drug

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Rovinskia VI (1989) A case of hallucinogen-like action of glaucine. Klin Med (Mosk) 67:107–108

    Google Scholar 

  2. Rovinskia VI (2006) Acute glaucine syndrome in the physician’s practice: the clinical picture and potential danger. Klin Med (Mosk) 84:68–70

    Google Scholar 

  3. Asencio M, Hurtado-Guzmán C, López JJ et al (2005) Structure-affinity relationships of halogenated predicentrine and glaucine derivatives at D1 and D2 dopaminergic receptors: halogenation and D1 receptor selectivity. Bioorg Med Chem 13:3699–3704

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul I. Dargan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dargan, P.I., Button, J., Hawkins, L. et al. Detection of the pharmaceutical agent glaucine as a recreational drug. Eur J Clin Pharmacol 64, 553–554 (2008). https://doi.org/10.1007/s00228-007-0451-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-007-0451-9

Keywords

Navigation